Teams from Cambridge University and Ireland seek genetic markers for disease
One of the most significant global efforts to develop multiple sclerosis (MS) treatments will see researchers from Ireland and Cambridge University come together to examine thousands of genetic samples.
GMI joins the battle to beat dementia as we formally launch our study researching Alzheimer’s disease. This issue was highlighted on The Pat Kenny Show yesterday morning featuring Professor Harry Vinters of the UCLA Brain Research Institute who also joined GMI for a talk on this important topic. Listen in to the highlights from the programme to learn more.
Transformational Research Aims to Unlock Keys to Lifelong Disorders including MS and IBD
Irish life sciences company, Genomics Medicine Ireland, is to collaborate with the Clinical Translational Research and Innovation Centre (C-TRIC), Western Health and Social Care Trust (Western Trust) and Ulster University to undertake comprehensive, population scale genomic research studies in Northern Ireland. (more…)
“Another life science company in the GV stable is Dublin-based Genomics Medicine Ireland, which has raised $40 million from GV and others to carry out genomic research across Ireland while examining the broader relationship between genetics, health, and disease.”